Reykjavik
Iceland
82
2014-09-18
36
2014-08-05
These are the the leading inventors for applications assigned to deCODE Genetics ehf.:
deCODE Genetics ehf. based in Reykjavik, IS has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#2 | 2014-09-04GENETIC VARIANTS ON CHR 11Q AND 6Q AS MARKERS FOR PROSTATE AND COLORECTAL CANCER PREDISPOSITION
#3 | 2014-08-14GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND STROKE
#4 | 2014-06-26GENETIC VARIANTS ON CHR 5P12 AND 10Q26 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT
#5 | 2014-03-27GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCER
#6 | 2014-03-20VARIANTS PREDICTIVE OF RISK OF GOUT
#7 | 2013-12-19GENETIC RISK FACTORS OF SICK SINUS SYNDROME
#8 | 2013-11-07Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
#9 | 2013-10-17GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCER
#10 | 2013-09-26GENETIC VARIANTS AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EOSINOPHILIA, ASTHMA, AND MYOCARDIAL INFARCTION
#11 | 2013-08-29GENETIC MARKERS FOR RISK MANAGEMENT OF VASCULAR DISEASE
#12 | 2012-10-18GENETIC VARIANTS INDICATIVE OF VASCULAR CONDITIONS
#13 | 2012-08-30 β Patent 8,796,182 granted on 2014-08-05Genetic markers associated with risk of diabetes mellitus
#14 | 2012-08-16GENETIC SUSCEPTIBILITY VARIANTS ASSOCIATED WITH CARDIOVASCULAR DISEASE
#15 | 2012-08-16SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#16 | 2012-07-19 β Patent 8,791,267 granted on 2014-07-29Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
#17 | 2012-06-14Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes Mellitus
#18 | 2012-05-17Genetic Variants Predictive of Cancer Risk in Humans
#19 | 2012-01-26 β Patent 8,795,963 granted on 2014-08-05Genetic markers for risk management of atrial fibrillation and stroke
#20 | 2011-12-01 β Patent 8,951,735 granted on 2015-02-10Genetic variants for breast cancer risk assessment
#21 | 2011-11-24Genetic Variants Useful for Risk Assessment of Thyroid Cancer
#22 | 2011-11-03Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
#23 | 2011-10-27 β Patent 8,808,985 granted on 2014-08-19Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm
#24 | 2011-09-22Genetic Variants Useful for Risk Assessment of Thyroid Cancer
#25 | 2011-09-01Genetic Variants Predictive of Cancer Risk
#26 | 2011-05-19GENETIC VARIANTS ON CHR2 AND CHR16 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENT
#27 | 2011-04-21 β Patent 8,828,657 granted on 2014-09-09Susceptibility variants for lung cancer
#28 | 2011-03-03 β Patent 8,697,360 granted on 2014-04-15Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
#29 | 2011-01-27Genetic Variants Contributing to Risk of Prostate Cancer
#30 | 2011-01-20 β Patent 8,580,501 granted on 2013-11-12Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
#31 | 2010-08-26Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
#32 | 2010-06-24 β Patent 8,367,333 granted on 2013-02-05Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
#33 | 2010-05-27CANCER SUSCEPTIBILITY VARIANTS ON CHR8Q24.21
#34 | 2010-05-13GENETIC VARIANTS USEFUL FOR RISK ASSESSMENTS OF CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION
#35 | 2010-03-18 β Patent 9,617,597 granted on 2017-04-11Genetic susceptibility variants associated with cardiovascular disease
#36 | 2010-02-25GENETIC VARIANTS ASSOCIATED WITH PERIODIC LIMB MOVEMENTS AND RESTLESS LEGS SYNDROME
#37 | 2009-12-31 β Patent 8,637,244 granted on 2014-01-28Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke
#38 | 2009-12-31BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS
#39 | 2009-12-24Variants at chr8q24.21 confer risk of cancer
#40 | 2009-11-26SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE
#41 | 2009-11-05Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
#42 | 2009-09-17BIARYL SUBSTITUTED NITROGEN CONTAINING HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION
#43 | 2009-06-25 β Patent 8,598,359 granted on 2013-12-03Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation
#44 | 2009-05-28BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#45 | 2009-05-21 β Patent 8,877,816 granted on 2014-11-044-(or 5-) substituted catechol derivatives
#46 | 2009-05-21 β Patent 8,883,833 granted on 2014-11-11Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
#47 | 2009-05-21SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS
#48 | 2009-01-29Sustained Release Formulation and Dosing Schedules of Leukotriene Synthesis Inhibitor for Human Therapy
#49 | 2008-10-23 β Patent 7,495,147 granted on 2009-02-24Neuregulin-1 transgenic mouse and methods of use
#50 | 2008-06-10 β Patent 7,384,736 granted on 2008-06-10Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
#51 | 2008-05-297-(ACRYLOYL) INDOLE COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#52 | 2008-04-17 β Patent 7,728,032 granted on 2010-06-01Phenoxymethylalkyne inhibitors of LTA4H for treating inflammation
#53 | 2008-02-07 β Patent 7,989,480 granted on 2011-08-02Aryl amino acid derivatives as inhibitors for treating inflammation
#54 | 2008-02-07 β Patent 8,115,005 granted on 2012-02-14Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
#55 | 2008-01-03Association of gene expression and psychiatric disoders
#56 | 2007-12-06 β Patent 8,158,362 granted on 2012-04-17Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
#57 | 2007-11-29 β Patent 7,435,548 granted on 2008-10-14Methods for producing ex vivo models for inflammatory disease and uses thereof
#58 | 2007-11-22 β Patent 7,579,483 granted on 2009-08-25Process for preparing 7-(acryloyl)indoles
#59 | 2007-06-28 β Patent 7,750,012 granted on 2010-07-06Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation
#60 | 2007-06-21 β Patent 7,674,802 granted on 2010-03-09N-linked aryl heteroaryl inhibitors of LTA4H for treating inflammation
#61 | 2007-06-21 β Patent 7,576,102 granted on 2009-08-18Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation
#62 | 2006-12-21 β Patent 7,585,630 granted on 2009-09-08Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
#63 | 2006-12-19 β Patent 7,152,073 granted on 2006-12-19Method and system for defining sets by querying relational data using a set definition language
#64 | 2006-12-12 β Patent 7,148,008 granted on 2006-12-12Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
#65 | 2006-11-16Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy
#66 | 2006-10-03 β Patent 7,115,586 granted on 2006-10-03Non-inclusion cyclodextrin complexes
#67 | 2006-04-13 β Patent 7,598,397 granted on 2009-10-06Sulfonamide peri-substituted bicyclics for occlusive artery disease
#68 | 2006-03-21 β Patent 7,016,910 granted on 2006-03-21Indexing, rewriting and efficient querying of relations referencing semistructured data
#69 | 2006-01-19Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association
#70 | 2005-12-29Susceptibility gene for human stroke; methods of treatment
#71 | 2005-12-22Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
#72 | 2005-12-08Methods of preventing or treating recurrence of myocardial infarction
#73 | 2005-09-29Human type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
#74 | 2005-09-22Human schizophrenia gene
#75 | 2005-09-08Human Type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
#76 | 2005-09-01 β Patent 7,244,571 granted on 2007-07-17Methods for producing Ex vivo models for inflammatory disease and uses thereof
#77 | 2005-07-28Susceptibility gene for human stroke: method of treatment
#78 | 2005-05-26 β Patent 7,851,486 granted on 2010-12-14Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
#79 | 2005-05-26 β Patent 7,507,531 granted on 2009-03-24Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
#80 | 2005-05-24 β Patent 6,897,027 granted on 2005-05-24Method for desalting nucleic acids
#81 | 2005-05-17 β Patent 6,893,828 granted on 2005-05-17Methods for producing ex vivo models for inflammatory disease and uses thereof
#82 | 2005-03-03Set definition language for relational data
36971 β